(6.ALPHA.,11.BETA.)-6,9-DIFLUORO-11,21-DIHYDROXY-17-(1-OXOBUTOXY)PREGNA-1,4-DIENE-3,20-DIONE
UNII 44L6C59WTE
Substance Identification & Data
This profile provides standardized clinical and technical data for (6.alpha.,11.beta.)-6,9-difluoro-11,21-dihydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 44L6C59WTE.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 23640-96-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H32F2O6 BQEJAAIPKDQEPV-MXHGPKCJSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (6.alpha.,11.beta.)-6,9-difluoro-11,21-dihydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.